New progress in personalizing treatment of sarcoma using AI
RI-MUHC researcher leads the development of the first multimodal deep learning model to optimize care for individual cancer patients
The elderly still take too many potentially inappropriate drugs
Study shows that despite some improvements, potentially inappropriate medications are still heavily prescribed to seniors in Canada and some are...
Bridging science and care: Enhancing parenting interventions for early childhood development
RI-MUHC researcher Marilyn Ahun publishes new work on the effects of multi-component parenting and mental...
New guidelines to better identify people at risk of heart attack and stroke
An international expert panel, co-chaired by Dr. Rhian Touyz of the RI-MUHC, recommends various measures...
RI-MUHC researchers introduce a scalable, cost-effective solution for single-cell profiling
An innovative computational tool, scSemiProfiler, makes powerful single-cell sequencing technology more...
Circadian rhythms appear to influence vulnerability to malaria parasites
A new discovery could lead to more effective treatment of malaria and other parasitic diseases.
Introducing peanuts earlier to reduce allergy risk
A recent study by the Research Institute of the McGill University Health Centre, using data from the Montreal Children's Hospital, reveals that introducing...
Dream discovery: Melatonin’s key role in REM sleep revealed
A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated...
A first-ever effective therapy for rare devastating neurodegenerative diseases
With the support of a nonprofit organization started by a patient’s family, rare disease expert Dr. Kenneth Myers...
Triple-negative breast cancer: new hope for an existing drug
RI-MUHC team takes another step toward precision medicine by targeting a biomarker of CDK4/6 inhibitor efficacy in breast cancer, including triple-negative...